TY - JOUR
T1 - Histaminergic neurons in the tuberomammillary nucleus as a control centre for wakefulness
AU - Yoshikawa, Takeo
AU - Nakamura, Tadaho
AU - Yanai, Kazuhiko
N1 - Funding Information:
This work was supported by a Grant‐in‐Aid for Scientific Research (C) (18K06886) from Japan Society for the Promotion of Science (JSPS) and also by Grant‐in‐Aid for Early‐Career Scientists (17K16753).
Publisher Copyright:
© 2020 The British Pharmacological Society
PY - 2021/2
Y1 - 2021/2
N2 - Histamine plays pleiotropic roles as a neurotransmitter in the physiology of brain function, this includes the maintenance of wakefulness, appetite regulation and memory retrieval. Since numerous studies have revealed an association between histaminergic dysfunction and diverse neuropsychiatric disorders, such as Alzheimer's disease and schizophrenia, a large number of compounds acting on the brain histamine system have been developed to treat neurological disorders. In 2016, pitolisant, which was developed as a histamine H3 receptor inverse agonist by Schwartz and colleagues, was launched for the treatment of narcolepsy, emphasising the prominent role of brain histamine on wakefulness. Recent advances in neuroscientific techniques such as chemogenetic and optogenetic approaches have led to remarkable progress in the understanding of histaminergic neural circuits essential for the control of wakefulness. In this review article, we summarise the basic knowledge about the histaminergic nervous system and the mechanisms underlying sleep/wake regulation that are controlled by the brain histamine system. LINKED ARTICLES: This article is part of a themed issue on Neurochemistry in Japan. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.4/issuetoc.
AB - Histamine plays pleiotropic roles as a neurotransmitter in the physiology of brain function, this includes the maintenance of wakefulness, appetite regulation and memory retrieval. Since numerous studies have revealed an association between histaminergic dysfunction and diverse neuropsychiatric disorders, such as Alzheimer's disease and schizophrenia, a large number of compounds acting on the brain histamine system have been developed to treat neurological disorders. In 2016, pitolisant, which was developed as a histamine H3 receptor inverse agonist by Schwartz and colleagues, was launched for the treatment of narcolepsy, emphasising the prominent role of brain histamine on wakefulness. Recent advances in neuroscientific techniques such as chemogenetic and optogenetic approaches have led to remarkable progress in the understanding of histaminergic neural circuits essential for the control of wakefulness. In this review article, we summarise the basic knowledge about the histaminergic nervous system and the mechanisms underlying sleep/wake regulation that are controlled by the brain histamine system. LINKED ARTICLES: This article is part of a themed issue on Neurochemistry in Japan. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.4/issuetoc.
KW - histamine
KW - sleep–wake cycle
KW - tuberomammillary nucleus
UR - http://www.scopus.com/inward/record.url?scp=85090953542&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090953542&partnerID=8YFLogxK
U2 - 10.1111/bph.15220
DO - 10.1111/bph.15220
M3 - Review article
C2 - 32744724
AN - SCOPUS:85090953542
SN - 0007-1188
VL - 178
SP - 750
EP - 769
JO - British Journal of Pharmacology
JF - British Journal of Pharmacology
IS - 4
ER -